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Abstract
New vaccine candidates were identified targeting the one celled parasite Ichthyophthirius multifiliis, which negatively affects aquaculture freshwater fish productions all over the world. In silico selection with the use of artificial 
intelligence identified several potential vaccine candidates and three of these were recombinantly expressed using E. coli and insect cells. Following a vaccine trial one protein (a so-called neurohypophysial n-terminal domain 
protein, #10) was found to induce moderate protection against I. multifiliis in rainbow trout (Oncorhynchus mykiss). To develop a highly protective heterologous vaccine we aim to combine #10 with a protective epitope from the 
already known homologous protective antigen Iag52b, which is a GPI-anchored cysteine rich surface protein. To be able to produce #10 at low costs, recombinant expression has been conducted in an eukaryotic host. Purified 
Iag52b does not induce immunity in fish without the use of adjuvants, thus the most potentially protective epitope of Iag52 was selected in silico and coupled to a virus-like particle. This coupling enables the epitope to be 
presented in a virus-like conformation, which theoretically should be immunogenic to the fish. 
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VLPs are immunogenic and 
can possibly replace adjuvants 
The improved vaccine will contain VLPs 
displaying both Iag52b epitopes and #10 
protein and will be injected with and 
without adjuvant. So far we have been 
able to produce VLPs with Iag52b 
epitopes to harvest in the supernatant 
from Pichia pastoris but protein #10 
however is withheld within the cells. We 
are modifying signal sequences but If we 
are unable to target the protein to the 
supernatant, cell material will instead be 
used for the vaccine. The overall 
ambition is to develop a low cost 
recombinant vaccine that induce a high 
level of protection against the 
economically devastating parasitic 
ciliate I. multifiliis without the 
use of adjuvants in a wide range 
of fresh water fish species.
U N I V E R S I T Y  O F  C O P E N H A G E N ,  F A C U L T Y  O F  H E A L T H  A N D  M E D I C A L  S C I E N C E S
An already described protective antigen from the surface of I. 
multifiliis, called Iag52b, has not successfully been expressed 
recombinantly in conventional expression systems. Therefore 
we have identified two potentially protective epitopes in silico 
for recombinant expression and fusion with VLPs
Parasite burden
ELISA showed that the 
group of fish injected with the 
experimental vaccine and the 
parasite homogenate erected 
antibodies against one of the 
recombinant proteins, #10 
(neurohypophysial n-terminal
domain protein)
Immobilization 
assay conducted with live 
parasites incubated in 
plasma from vaccinated fish 
showed that the experimental 
vaccine and the parasite 
homogenate immobilized the 
parasites moderately.  
The parasite 
burden was 
significantly reduced in 
the subunit and the 
parasite homogenate 
vaccine groups. We 
estimated the protection 
to be moderate.
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Virus-like 
conformation
The proteome of 
Ichthyophthirius multifiliis
was screened using artificial 
intelligence in silico and 12 
vaccine candidates were 
further investigated. Out of 
these, recombinant 
production was achieved for 
7 proteins. Following a pilot 
study 3 proteins were 
selected as vaccine 
candidates. 
A total of 190 fish were
divided into five duplicated 
groups with 20 fish per 
replicate. Each fish in the 
recombinant vaccine 
group received 150 µL of 
vaccine consisting of equal 
amounts of alhydrogel and 
FIA with a mixture of the 
recombinant proteins 
bound to alhydrogel. 
Challenge was conducted 
by adding a suspension of 
theronts (10,000 theronts 
per fish) to the fish tank. 
Filtration was removed for 
the first 4 hours during 
challenge. 
